Andrea Lippold

1.4k total citations
28 papers, 959 citations indexed

About

Andrea Lippold is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Andrea Lippold has authored 28 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 15 papers in Molecular Biology and 8 papers in Dermatology. Recurrent topics in Andrea Lippold's work include Cutaneous Melanoma Detection and Management (23 papers), Melanoma and MAPK Pathways (9 papers) and Nonmelanoma Skin Cancer Studies (7 papers). Andrea Lippold is often cited by papers focused on Cutaneous Melanoma Detection and Management (23 papers), Melanoma and MAPK Pathways (9 papers) and Nonmelanoma Skin Cancer Studies (7 papers). Andrea Lippold collaborates with scholars based in Germany, United States and Switzerland. Andrea Lippold's co-authors include A. Peters, H. Drepper, Claus Garbe, Waltraud Stroebel, G. Rassner, B dʼHoedt, I. Guggenmoos-Holzmann, J. Bertz, Petra Büttner and W. Lechner and has published in prestigious journals such as Cancer, Cancer Research and Journal of the American Academy of Dermatology.

In The Last Decade

Andrea Lippold

28 papers receiving 930 citations

Peers

Andrea Lippold

ONCOL

EPIDE

DERMA

IMMUN

Lutz Kretschmer Germany

Lee Hagendoorn United States

Hans Starz Germany

Patrick Hennessey United States

Ling-Xi L. Li Australia

Andrea Maurichi Italy

H. Drepper Germany

Hans Peter Bertsch Germany

Vincent J. McGovern Australia

Roberto Patuzzo Italy

Lutz Kretschmer Germany

Andrea Lippold

765 ×1.0

ONCOL

286 ×0.8

338 ×1.2

EPIDE

174 ×0.8

DERMA

157 ×0.9

IMMUN

Citations per year, relative to Andrea Lippold Andrea Lippold (= 1×) peers Lutz Kretschmer

Countries citing papers authored by Andrea Lippold

Since Specialization

Citations

This map shows the geographic impact of Andrea Lippold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Lippold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Lippold more than expected).

Fields of papers citing papers by Andrea Lippold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Lippold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Lippold. The network helps show where Andrea Lippold may publish in the future.

Co-authorship network of co-authors of Andrea Lippold

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Lippold. A scholar is included among the top collaborators of Andrea Lippold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Lippold. Andrea Lippold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brunner, Georg, Martina Reitz, Achim Heinecke, et al.. (2012). A nine-gene signature predicting clinical outcome in cutaneous melanoma. Journal of Cancer Research and Clinical Oncology. 139(2). 249–258. 52 indexed citations

Brunner, Georg, Martina Reitz, A. Heinecke, et al.. (2009). 25LBA A novel highly prognostic nine gene signature can change the algorithm of adjuvant alfa-interferon in malignant melanoma at 1st diagnosis. European Journal of Cancer Supplements. 7(3). 14–14. 1 indexed citations

Brunner, Georg, Martina Reitz, V. Schwipper, et al.. (2008). Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients. Cancer Biotherapy and Radiopharmaceuticals. 23(4). 451–460. 30 indexed citations

Breitkopf, Claudia, et al.. (2007). Late adverse effects after soft X‐ray therapy of cutaneous malignancies: pruritus, burning, epiphora and insufficient occlusion of the mouth. Journal of the European Academy of Dermatology and Venereology. 22(5). 555–560. 1 indexed citations

Fluck, Michael, Darab Kamanabrou, Andrea Lippold, Martina Reitz, & Jens Atzpodien. (2005). Dose-Dependent Treatment Benefit in High-Risk Melanoma Patients Receiving Adjuvant High-Dose Interferon Alfa-2b. Cancer Biotherapy and Radiopharmaceuticals. 20(3). 280–289. 2 indexed citations

Kölmel, K.F., Bettina Kulle, Andrea Lippold, & C Seebacher. (2002). Survival probabilities and hazard functions of malignant melanoma in Germany 1972–1996, an analysis of 10 433 patients. Evolution of gender differences and malignancy. European Journal of Cancer. 38(10). 1388–1394. 27 indexed citations

Kölmel, K.F., et al.. (2001). Zur Sterblichkeit am kutanen invasiven malignen Melanom. Der Hautarzt. 52(3). 211–218. 4 indexed citations

Otto, F., et al.. (2001). Prognostic immunohistochemical markers of primary human melanomas. British Journal of Dermatology. 145(2). 203–209. 43 indexed citations

Otto, Friedrich, et al.. (1999). Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?. Cancer. 85(11). 2391–2399. 67 indexed citations

10.

Goldmann, Torsten, et al.. (1999). Prognostic Classification of Malignant Melanomas by Combining Clinical, Histological, and Immunohistochemical Parameters. Oncology. 56(3). 208–214. 25 indexed citations

11.

Hundeiker, M, Andrea Lippold, & A. Peters. (1997). Metastasierende Melanome geringer Breslow-Dicke. Der Hautarzt. 48(3). 171–174. 2 indexed citations

12.

Peters, A., Andrea Lippold, & M Hundeiker. (1997). Melanomerstmetastasen nach 10 und mehr Jahren Erscheinungsfreiheit. Der Hautarzt. 48(5). 311–317. 18 indexed citations

13.

Garbe, Claus, Petra Büttner, J. Bertz, et al.. (1995). Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer. 75(10). 2484–2491. 163 indexed citations

14.

Garbe, Claus, Petra Büttner, J. Bertz, et al.. (1995). Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer. 75(10). 2492–2498. 162 indexed citations

15.

Breuninger, Helmut, H. Drepper, Boris C. Bastian, et al.. (1994). Ist das akrolentigin�se Melanom (ALM) maligner als das superfiziell spreitende Melanom (SSM) in einer High-risk-Lokalisation?. Der Hautarzt. 45(8). 529–531. 11 indexed citations

16.

Drepper, H., M Hundeiker, Andrea Lippold, et al.. (1993). The prognosis of patients with stage III melanoma prospective long-term study of 286 patients of the fachklinik hornheide. Cancer. 71(4). 1239–1246. 40 indexed citations

17.

Drepper, H., Boris C. Bastian, Helmut Breuninger, et al.. (1993). Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer. 72(3). 741–749. 57 indexed citations

18.

Gartmann, H, et al.. (1992). The usefulness of single and combined clinical characteristics for the diagnosis of dysplastic naevi. Melanoma Research. 1(5). 377–384. 2 indexed citations

19.

Bartkowiak, Detlef, et al.. (1991). Sequential DNA Flow Cytometry in Metastatic Malignant Melanoma. Oncology. 48(2). 154–157. 7 indexed citations

20.

Bartkowiak, Detlef, et al.. (1991). DNA Flow Cytometry in the Prognosis of Primary Malignant Melanoma. Oncology. 48(1). 39–43. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact